Company Overview of Intersect ENT Inc.
Intersect ENT, Inc., a commercial stage drug-device company, provides therapeutic solutions for patients with ear, nose, and throat conditions in the United States. It offers PROPEL and PROPEL mini drug-eluting implants for patients undergoing sinus surgery to treat chronic sinusitis. The company was formerly known as Sinexus, Inc. and changed its name to Intersect ENT, Inc. in November 2009. Intersect ENT, Inc. was founded in 2003 and is headquartered in Menlo Park, California.
1555 Adams Drive
Menlo Park, CA 94025
Founded in 2003
Key Executives for Intersect ENT Inc.
Chief Executive Officer
Total Annual Compensation: $334.8K
Chief Operating Officer and Senior Vice President
Total Annual Compensation: $293.2K
Vice President of Sales
Total Annual Compensation: $154.5K
Compensation as of Fiscal Year 2013.
Intersect ENT Inc. Key Developments
Intersect ENT Inc.(NasdaqGM:XENT) added to NASDAQ Composite Index
Jul 25 14
Intersect ENT Inc. will be added to the NASDAQ Composite Index.
Intersect ENT Inc. Appoints Cynthia L. Lucchese to Board of Directors
Jul 23 14
Intersect ENT has appointed Cynthia L. Lucchese to the company's board of directors. Lucchese will serve as chair of the audit committee and as a member of the nominating and governance committee. Lucchese most recently served as senior vice president and chief financial officer of Hillenbrand, and as a member of the board of directors of Brightpoint, where she served as chair of the audit committee. Previously, Lucchese was senior vice president and chief financial officer for Thoratec and she held a variety of finance roles, including vice president and treasurer and chief accounting officer at Guidant, now a part of Boston Scientific. She also spent seven years with Eli Lilly and Company and several years with the audit division of Ernst & Young.
Intersect ENT, Inc. Appoints Cynthia L. Lucchese to Board of Directors
Jul 11 14
Intersect ENT Inc. announced the appointment of Cynthia L. Lucchese to the company's board of directors. Ms. Lucchese will serve as chair of the audit committee and as a member of the nominating and governance committee. Ms. Lucchese most recently served as Senior Vice President and Chief Financial Officer of Hillenbrand Inc. and as a member of the board of directors of Brightpoint Inc.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries